Skip to content

Form 4 filed by PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc. filed this Form 4 on QCLS (Q/C TECHNOLOGIES, INC.) with 3 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-21 01:30:00 UTC.

Accession
0001683168-26-009018
Filed
2026-11-20
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: QCLS · Q/C TECHNOLOGIES, INC. (CIK 1321834)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common stock 2026-11-18X exercised+4,982,272$05,152,000D
Series G Long-Term Warrants derivative2026-11-18X exercised-851,304$013,318,344D
Series H Convertible Preferred Stock derivative2026-11-18J other+3,000$03,000D